Clinical Trials Browser

Phase 2 × Chordoma × camrelizumab × Clear all

NCT06140732 2023-11-20

Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma

Phase 2 Unknown

Chordoma